Wynnefield Capital Management »

Halozyme Therapeutics shares owned by Wynnefield Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Wynnefield Capital Management from 13F filings

Historical chart of Wynnefield Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Wynnefield Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Wynnefield Capital Management

Quarter filed Position value Share count Share price at filing
2011-09-30 $1.2M 200k 6.14
2011-06-30 $163k 24k 6.91
2011-03-31 $114k 17k 6.71